Have a feature idea you'd love to see implemented? Let us know!
Back to SUPN overview

SUPN Supernus Pharmaceuticals PE ratio, current and historical analysis

The current P/E ratio for Supernus Pharmaceuticals stock as of Dec 5, 2024 is 34.25. This is calculated based on the TTM EPS of $1.08 and the stock price of $36.99 per share.

SUPN PE ratio history

How has SUPN's PE ratio performed in the past

The average historical PE ratio of Supernus Pharmaceuticals for the last ten years is 76.32. The current price-to-earnings ratio of 34.25 is 55% less than the historical average. Analyzing the last ten years, SUPN's PE ratio reached its highest point in the Dec 2023 quarter at 1,447, when the price was $28.94 and the EPS was $0.02. The lowest point was recorded in the Mar 2020 quarter, when it reached 8.14 with a price of $17.99 and an EPS of $2.21.

Average
76.32
Median
27.7
Minimum
8.14
Maximum
1,447

Supernus Pharmaceuticals PE ratio by year

Maximum annual increase: 4,483.47% in 2023

Maximum annual decrease: -70.39% in 2016

Year PE ratio Change
2023 1,447 4,483.47%
2022 31.57 9.35%
2021 28.87 176.53%
2020 10.44 -4.92%
2019 10.98 -29.62%
2018 15.6 -55.77%
2017 35.27 157.07%
2016 13.72 -70.39%
2015 46.34 N/A
2014 N/A N/A

SUPN average PE ratio chart

What is the average PE ratio of SUPN for the past years

The current PE ratio of SUPN is under its 3, 5 and 10-year averages.

3-year avg
187.77
5-year avg
113.68
10-year avg
76.32
15-year avg
N/A

SUPN PE vs peers

What is SUPN's PE ratio compared to its peers

SUPN's PE ratio is less than its peer stocks LLY and ABT, but it is above JNJ's and UTHR's. Supernus Pharmaceuticals is currently trading at a lower PE ratio (34.25) than its peers average of 41.03.

Stock name PE ratio Market cap
UTHR UNITED THERAPEUTICS Corp 15.43 $16.74B
JNJ Johnson & Johnson 24.81 $360.24B
SUPN Supernus Pharmaceuticals Inc 34.25 $2.04B
ABT Abbott Laboratories 35.14 $201.14B
LLY ELI LILLY & Co 89.65 $790.68B
BMY Bristol Myers Squibb Co N/A $119.76B

Frequently asked questions

What is Supernus Pharmaceuticals's PE ratio?

The price to earnings ratio for SUPN stock as of Dec 5, 2024, stands at 34.25.

What is the 3-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 3 years, the average PE ratio for SUPN stock is 187.77.

What is the 5-year average PE ratio for Supernus Pharmaceuticals (SUPN)?

Over the last 5 years, the average PE ratio for SUPN stock is 113.68.

What is the highest PE ratio for SUPN?

The highest quarterly PE ratio in the last ten years has been 1,447 and it was in the Dec 2023 quarter.

How does the current PE ratio for SUPN compare to its historical average?

The current PE ratio of SUPN is 55% lower than the 10-year historical average.

How is SUPN's PE ratio calculated (Supernus Pharmaceuticals PE ratio formula)?

The P/E ratio is calculated by taking the latest stock price and dividing it by the earnings per share(EPS) for the last 12 months. As of today (Dec 5, 2024), Supernus Pharmaceuticals's share price is $36.99. The company's earnings per share for the trailing twelve months (TTM) ending Sep 2024 is $1.08. Therefore, Supernus Pharmaceuticals's price to earnings ratio for today is 34.25. PE RATIO(34.25) = STOCK PRICE($36.99) / TTM EPS($1.08)

All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from and Sharadar.